Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(3):200-201; doi:10.1093/jnci/91.3.200
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Critchlow, C. W.
Right arrow Articles by Kiviat, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Critchlow, C. W.
Right arrow Articles by Kiviat, N. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 3, 200-201, February 3, 1999
© 1999 Oxford University Press

EDITORIALS

Old and New Issues in Cervical Cancer Control

Cathy W. Critchlow, Nancy B. Kiviat

Affiliations of authors: C. W. Critchlow (Department of Epidemiology, School of Public Health and Community of Medicine), N. B. Kiviat (Departments of Pathology and Medicine, School of Medicine), University of Washington, Seattle.

Correspondence to: Nancy B. Kiviat, M.D., HPV Research Group,6 Nickerson, Suite 310, Seattle, WA 98109 (e-mail: nbk@u.washington.edu).

Clearly, one of the public health successes of the last 50 years has been the development of an effective approach to cervical cancer control. Dramatic decreases in the incidence of invasive cervical cancer (ICC) have occurred following the establishment of routine cytologic screening and treatment of those lesions (severe dysplasia or carcinoma in situ [CIS]) thought to be immediate precursors of ICC. Although it is widely agreed that the aim of cervical cytologic screening should be the identification of all women with these high-grade lesions, there is little agreement as to how best to achieve this. Until recently, in many countries such as Canada, physicians primarily relied on cytology alone to identify women with severe dysplasia/CIS, with referral for colposcopy largely reserved for confirmation of the cytologic diagnosis. However, in . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
I. Nyirjesy
Re: Natural History of Dysplasia of the Uterine Cervix
J Natl Cancer Inst, August 18, 1999; 91(16): 1420 - 1420.
[Full Text] [PDF]